Table 2.
Univariate and multivariable Cox regression analysis on overall survival.
| Univariate Cox | Multivariate Cox | |||||
| Variables | HR | 95% CI | P-value | HR | 95% CI | P-value |
| TYK2 (high vs low) | 0.351 | 0.194 to 0.637 | <.001 | 0.36 | 0.185 to 0.699 | .003 |
| Age (>60 vs ≤60) | 0.806 | 0.454 to 1.429 | .46 | 0.774 | 0.416 to 1.441 | .419 |
| Gender (male vs female) | 0.297 | 0.151 to 0.586 | <.001 | 0.508 | 0.279 to 0.714 | .009 |
| AJCC stage (III–IV vs I–II) | 0.782 | 0.366 to 1.672 | .057 | 0.823 | 0.192 to 3.524 | .793 |
| Tumor stage (T3–4 vs T1–2) | 1.451 | 1.363 to 1.656 | .044 | 1.017 | 0.292 to 3.541 | .978 |
| Lymph node status (N2–3 vs N0–1) | 1.894 | 1.060 to 3.383 | .038 | 1.996 | 1.013 to 3.935 | .046 |
| Metastasis (M1 vs M0) | 4.86 | 1.670 to 14.146 | .004 | 2.147 | 1.632 to 7.292 | .021 |
| Race (White vs no White) | 1.421 | 0.748 to 2.699 | .284 | 0.587 | 0.286 to 1.203 | .146 |
| Alcohol history (no vs yes) | 1.497 | 0.846 to 2.650 | .166 | 1.273 | 0.670 to 2.421 | .461 |
| Smoking history (no vs yes) | 1.061 | 0.588 to 1.912 | .166 | 1.134 | 0.604 to 2.129 | .695 |
CI = confidence interval, HR = hazard ratio, TYK2 = tyrosine kinase 2.